New Covid strain that could evade protection from vaccine found in UK

A new Covid variant has also been detected in the UK, spreading across the US, health chiefs have warned.

The strain, known as BA.3.2, was detected in nasal swabs from four American travelers and clinical samples from five patients in four unidentified states.

It was also found in three airplane wastewater samples and 132 other samples taken in more than 20 states, indicating that it spreads much more widely than scientists can currently see.

US scientists also expressed concerns that current vaccines may not protect against this variant.

According to the United Kingdom Health Safety Agency (UKHSA), the strain has also been detected in the United Kingdom and is currently being monitored.

UKHSA consultant virologist Dr. Nick Machin said: “UKHSA continually monitors all available data on emerging variants of SARS-CoV-2 through our surveillance programmes. As part of our routine surveillance, we regularly conduct analyzes of the severity and detectability of the virus.”

“BA.3.2 has been designated a ‘variant under monitoring’ by the World Health Organization and has been detected in the United Kingdom.”

The variant is derived from another variant of Covid, Omicron, and was first detected in South Africa in 2024. The variant began to increase in September 2025 and has since been reported in 23 countries.

Omicron was first detected in Botswana and spread to the United Kingdom in December 2021. The variant has caused an alarming rise in cases due to its high transmission rate, putting significant pressure on the NHS.

Researchers at the Centers for Disease Control and Prevention warned that the new strain is “genetically distinct” from other JN.1 strains previously circulating in the United States. Morbidity and Mortality Weekly Report.

BA.3.2 carries about 70 to 75 genetic changes in the spike protein, a part of the coronavirus that allows it to enter human cells. This means it may be easier for the virus to spread and evade immune protection.

“The 2025-2026 LP.8.1-adapted mRNA Covid-19 vaccine shows protection against the currently dominant JN.1 strains but had the lowest antibody neutralization against BA.3.2 in a laboratory study of seven variants, potentially impacting the protection provided by the vaccine,” the researchers said.

Although new, there is currently no evidence that this strain of Covid causes more severe disease than previous variants of the virus, according to the UKHSA.

“We are currently conducting an assessment of its impact on diagnostic test performance and will provide further guidance to laboratories where necessary,” Dr Machin added.

“There is no evidence to date that this variant is more transmissible or causes more severe disease than other new variants.”

Scientists in the UK do not currently believe this variant poses any more of a threat than other strains.

Professor Ian Jones, a virologist at the University of Reading, said: “We might expect continued evolution to make transmission easier, but unless there is a rise in hospital cases there is no reason to assume that any new variant is more ‘dangerous’.” Independent.

He explained that the decision to update a vaccine due to mutations would likely be “more of a commercial decision than a scientific decision.”

“If a company feels that its vaccine is losing purchasing power due to lack of efficacy, it will update its vaccine but will not respond to every change that arises until then,” he explained.

Prof Jones emphasized that the population now has immunity against Covid and that the vaccine keeps the disease “under control”, although it does not protect against all strains.

He said: “I think we can have some confidence in the fact that the monitoring systems detected this early, but it’s probably ‘just another variable’ that needs to be taken into account, but nothing more for now.”

Professor Paul Hunter, an epidemiologist at the University of East Anglia, said he was “doubtful” Covid would “one day disappear” and that the new variant did not surprise him.

“As long as humans continue to live on the planet, we will continue to see new variants of the virus,” he said. Independent.

“The issue is whether the new variant poses a significant increased risk to public health. Any new variant that competes with other variants is likely to increase infection rates, but this does not mean that it will lead to a significant additional burden of disease,” he added.